Editors' ChoiceCancer

Activating β-Catenin with NCAM

See allHide authors and affiliations

Science Signaling  26 Jul 2011:
Vol. 4, Issue 183, pp. ec205
DOI: 10.1126/scisignal.4183ec205

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • GSK-3 and β-catenin

    Dear Nancy,

    Your Editors' Choice on the effect of N-CAM on β-catenin failed to note that the phosphorylation state of GSK-3 (either alpha or β) has no effect on β-catenin levels in cells. Phosphorylation of Serine 9 (GSK-3β) or Serine 21 (GSK-3alpha...

    Show More
    Competing Interests: None declared.

Stay Connected to Science Signaling